Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modigraf pharmacokinetic study in de novo pediatric allograft recipients
2009-012258-19Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mycophenolate mofetil in Transplant rejection prophylaxis, sponsored by Astellas Pharma. Primary endpoint: Tacrolimus pharmacokinetic parameters after morning dose on Day 1 and Day 7 (+7 days). Started Jan 2011; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Transplant rejection prophylaxis
Beyond the preview
Go deeper on 2009-012258-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012258-19.